Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Warby Parker's EBITDA for the
three
months ended in Jun. 2026 was MXN301 Mil. Warby Parker's Revenue for the
three
months ended in Jun. 2026 was MXN4,109 Mil. Therefore, Warby Parker's EBITDA margin for the quarter that ended in Jun. 2026 was 7.32%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Warby Parker EBITDA Margin % Related Terms
Warby Parker EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Warby Parker's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:WRBY vs XRAY, LMAT, PLSE: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Warby Parker's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Warby Parker EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Warby Parker's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Warby Parker's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warby Parker (MEX:WRBY) has a EBITDA Margin % of 7.32% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Warby Parker and its competitors. According to the industry distribution chart, Warby Parker ranks #434 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 53.2%.
Is Warby Parker's EBITDA Margin % too high?
Warby Parker's current EBITDA Margin % is 7.32%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.59. Warby Parker's value of 7.32% is 3.6% below this industry median. Based on the distribution chart, Warby Parker ranks #434 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Warby Parker has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Warby Parker's EBITDA Margin % compare to XRAY and LMAT?
According to the Medical Devices & Instruments industry distribution chart, Warby Parker ranks #434 out of 816 companies for EBITDA Margin %. This places Warby Parker in the lower half of its industry. The industry median EBITDA Margin % is 7.59. Warby Parker's value of 7.32% is 3.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.59, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Warby Parker's current EBITDA Margin % of 7.32% is 3.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Warby Parker and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Warby Parker's current EBITDA Margin % is 7.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Warby Parker stock overvalued right now?
Warby Parker (MEX:WRBY) has a current EBITDA Margin % of 7.32%. The stock's GF Value™ is MXN302.34, compared to a current price of MXN369.50 — trading 22.2% above its estimated fair value. The current EBITDA Margin % is 7.32% and 3.6% below the Medical Devices & Instruments industry median of 7.59. Warby Parker's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Warby Parker (MEX:WRBY), the current EBITDA Margin % is 7.32% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Warby Parker (MEX:WRBY) Overvalued in 2026?
Based on GuruFocus' analysis, Warby Parker stock appears to be overvalued.
The current stock price of MXN369.50 is trading 22.2% above its estimated GF Value™ of MXN302.34.
Key valuation signals for MEX:WRBY:
EBITDA Margin %: 7.32%
GF Value™: MXN302.34 vs. price of MXN369.50 (22.2% above fair value)
Industry Position: 3.6% below the Medical Devices & Instruments median (#434 of 816)
No single metric tells the full story. See the MEX:WRBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
69GF Score
Get the complete analysis for MEX:WRBY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:WRBY has been successfully added to your 
